BioSpace News Archive

Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, announces the appointment of Matthew Onaitis as Chief Financial Officer, effective August 20, 2018.

U.S. patients and hospitals alike are sick of a system that leaves 25% of Americans with unaffordable healthcare expenses.

Rimidi today announced that Jim Clifford has joined the company as Vice President of Strategic Sales.

Harrington was born and raised in the Berkshires.

Fully renovated 44,000-square-foot building located in Schaumburg, Illinois, is ENA’s seventh home

Walgreens launches new marketing campaign to drive awareness about the importance of getting flu shots

Xcel Energy is on track to achieve one of the most ambitious carbon reductions goals in the industry, and the company has documented its progress in a new reporting tool that provides more uniform sustainability metrics for the industry.

Universal Health Systems, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the Baird 2018 Global Healthcare Conference in New York, NY, on Wednesday, September 5, 2018

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

One of the nation’s premier cancer centers now offers multidisciplinary cancer care in the region